North Dakota Senate Bill SB2399

North Dakota 2026 1st Special Session

Caption

AN ACT to create and enact a new section to chapter 50-24.1 of the North Dakota Century Code, relating to medical assistance reimbursement of psychiatric residential treatment facilities; to provide for a legislative management report; and to provide an appropriation.

Summary

Senate Bill No. 2399 aims to amend the North Dakota Century Code regarding medical assistance reimbursement for psychiatric residential treatment facilities. The bill mandates the Department of Health and Human Services to revise its reimbursement rules to cover direct care costs, including expenses related to clinical supervisors, medical directors, family engagement in care, and therapeutic leave days. Additionally, it sets a cap on administrative costs and specifies that reimbursements for therapeutic leave days shall not exceed $500 per day, with the implementation of utilization controls for these services.

Impact

The passage of SB2399 will significantly impact the reimbursement structure for psychiatric residential treatment facilities in North Dakota. By establishing new rules for reimbursement, the bill aims to ensure that facilities receive adequate funding for direct care services while promoting value-based care. The appropriation of over $1.3 million for the biennium will support these changes, potentially improving the quality of care provided to individuals in these facilities and enhancing the overall mental health services landscape in the state.

Sentiment

The sentiment surrounding SB2399 appears to be largely positive, as evidenced by the strong support it received in both the Senate and House votes, with 45-2 and 90-3 votes respectively. Stakeholders in the mental health community have expressed appreciation for the bill's focus on improving reimbursement for psychiatric care, indicating a recognition of the need for better funding in this area.

Contention

While the bill has received broad support, there may be some contention regarding the specifics of the reimbursement rates and the implementation of utilization controls. Some stakeholders may argue that the cap on therapeutic leave reimbursements could limit facilities' ability to provide comprehensive care, while others may raise concerns about the administrative burden associated with the new rules. However, no significant opposition was noted during the discussions leading up to the vote.